Home
BioDelivery Sciences International, Inc.

BioDelivery Sciences Int... Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domainbdsi.com

Year Founded1997

Employees201 - 500

Annual Revenue$100M - $200M

BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc. (including company regionals)

bdsi.com

See more website traffic and engagement information

BioDelivery Sciences International, Inc. Revenue up to May 2026 is 100M - 200M

revenue generated by BioDelivery Sciences International, Inc. top domains

BioDelivery Sciences International, Inc. top domains revenue over 3 years

Revenue for BioDelivery Sciences International, Inc. top domains

bdsi.com100M - 200M

See more with Sales Intelligence

Total visits to BioDelivery Sciences International, Inc.'s top domains

Understand BioDelivery Sciences International, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in BioDelivery Sciences International, Inc.'s top domains

Analyze BioDelivery Sciences International, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on BioDelivery Sciences International, Inc.'s top domains

See how BioDelivery Sciences International, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

BioDelivery Sciences International, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

google.comCompany NameGoogleEmployees> 10001HQUnited States, California, Mountain ViewAnnual revenue> $1BTotal visits88.9BComputers Electronics and Technology > Search Engines

Top technologies used by BioDelivery Sciences International, Inc.

These are the website technologies, by industry, used by BioDelivery Sciences International, Inc. top domains

Payment & Currencies (8)

Cart Functionality

Advertising (5)

Google Adsense

Widget (5)

Twemoji

Conversion & Analytics (3)

Google Analytics

More Technologies

10

See all

News & Signals from BioDelivery Sciences International, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioDelivery Sciences International launched ELYXYB TM (celecoxib oral solution on Feb 24th '22.BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine RALEIGH, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced the U.S. commercial launch and availability of ELYXYB TM (celecoxib oral solution), the first and only FDA-approved ready-to-use oral solution for the acute treatment of migraine with or without aura in adults.

NewsBioDelivery Sciences International hired John Golubieski as Chief Financial Officer on Oct 21st '21.BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced the appointment of John Golubieski as Chief Financial Officer, effective November 4, 2021.

NewsBioDelivery Sciences International promotes Terry Coelho to Executive Vice President and Chief Financial Officer.BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, promoted its Chief Financial Officer, Terry Coelho, to Executive Vice President and Chief Financial Officer.